A one month old female infant was brought to Rahima Moosa Mother and Child Hospital, Johannesburg, South Africa with non-specific symptoms of crying and irritability by a social worker before being taken to a place of safety. Her mother had been admitted to the local adult hospital, but her diagnosis was not known at that time. Further history was unavailable, however, it was known that the baby was HIV-exposed and was living in poor social conditions. According to the social worker, she had been crying inconsolably, feeding poorly and had vomited several times. On examination, she was symmetrically growth restricted: weight, height and head circumference were all below 2 standard deviations under the mean for term infants. There were no dysmorphic features. She was noted to have oral candidiasis, wasting, sparse hair, mild napkin dermatitis and was pyrexial with a temperature of 38.5°C. The cardio-respiratory examination was normal. On neurological examination, she was irritable with hypertonicity, but no neck stiffness was present. Fontanelles were open but not bulging.
Laboratory investigations revealed a white cell count of 14.5x10 9 /l, haemoglobin level of 10g/dl and thrombocytosis of 524x10 9 /l. Blood and urine cultures were negative. Chest x-ray showed a bilateral patchy nodular infiltrate with air bronchograms. Hilar lymphadenopathy was difficult to ascertain owing to the infiltrate. The tuberculin skin test (TST) was nonreactive (0mm). HIV-DNA PCR was positive with a CD4 count of 1013x10 6 /l (18%). A lumbar puncture was performed and cerebrospinal fluid (CSF) analysis revealed 20 polymorphonuclear cells, 10 lymphocytes and >10000 erythrocytes/mm 3 (this was considered consistent with a traumatic spinal tap); protein 0.58g/l, and glucose 3.0mmol/l. A Gram stain did not reveal the presence of any bacteria. Considering that her HIV-infected mother had been admitted with an unknown diagnosis and that she had clinical features consistent with meningitis, an India ink stain and cryptococcal latex antigen test (CLAT) were requested. The CSF India ink was negative but CSF CLAT was positive with a titre of 16.
Treatment with intravenous amphotericin B was initiated and a blood specimen for CLAT was sent. This CLAT was also positive though no titres were reported. CLATs were repeated on these initial CSF and blood specimens and the results confirmed. A second lumbar puncture repeated 48 hours after initiation of antifungal therapy, had 0 polymorphonuclear cells, 11 lymphocytes and 14 erythrocytes/mm 3 , protein 0.26g/l, glucose 3.0mmol/l and was CLAT negative; Blood cytomegalovirus (CMV)-PCR was positive with a CMV viral load of 17 000 copies/ml. It was suspected that the initial CSF result was as a result of antigen present in the blood mixed with CSF and that the child did not in fact have cryptococcal meningitis. All the available blood and CSF specimens from the mother and baby, including the initial positive CSF specimen, were sent to the National Health Laboratory Services, Mycology Reference Unit for lateral flow assay (LFA) and enzyme immunoassay (EIA) which confirmed the absence of cryptococcal antigen in all specimens examined. Cultures on both CSF specimens were negative for cryptococcus and other pathogens. Amphotericin B was discontinued after 7 days of therapy. The infant was treated for bacterial meningitis with intravenous ceftriaxone for 8 days, and highly active antiretroviral therapy (HAART) was then initiated. The fever resolved and her weight and clinical condition improved. She was discharged 17 days after admission. Mycobacterial culture of blood and CSF were negative.
It subsequently emerged that the child's mother had pancytopaenia and a pleural effusion and was being investigated for mycobacterial disease. She was not being treated for cryptococcosis and her blood cryptococcal latex antigen test was negative.
DISCUSSION
Cryptococcosis is a systemic mycosis which is the commonest cause of meningitis in the adult HIV population in South Africa [1] . Available data suggest it is uncommon in children and rare in neonatesGonzalez et al. reported an incidence of 0.85% among 473 children over 8 years. All patients were severely immunocompromised and older than 10 years of age [2] . A Malawian case series published in 1997 described the first three African paediatric cases in patients aged 6 weeks to 9 years [3] and an 2002
Indian report is believed to be the first described neonatal case of cryptococcal meningitis [4] . The route of transmission to neonates remains uncertain. Since Cryptococcus neoformans is ubiquitous in the environment, repeated exposure may be one mode of transmission [5] . Vertical transmission has only been described twice before [6, 7] , where the mothers presented with pneumonia and/or central nervous system manifestations of cryptococcosis and the neonates subsequently grew C. neoformans on blood culture. A Brazilian case report described a case of transmission from mother to child by probable peripartum haematogenous dissemination [7] . Neonatal cases occur predominantly in premature infants.
A retrospective cohort study between 1985 and 1996, investigated 30 children (median age 9.8 years) and found increasing incidence of cryptococcosis with age and worsening immune function [5] . Thus, clinical suspicion should be raised in severely immunocompromised older children presenting with fever and headaches.
Most laboratories rely on India ink staining, cryptococcal latex agglutination and organism culture for diagnosing cryptococcosis, with culture considered the gold standard. Commercially available latexagglutination tests have a sensitivity and specificity of 93-100% and 93-98% respectively for CSF specimens [9] . False-positive test results may occur (see Table) , but are uncommon [8] . It is recommended that specimens should be pre-treated with proteolytic enzymes ( pronase) and reduced by use of 2-β-mercaptoethanol or dithiothreitol to avoid cross-reactions resulting from the causes described in the Table. The NHLS laboratory which performed the CLATs on our specimens routinely pre-treat all serum and blood-stained CSF specimens with pronase. Soaps and disinfectants used in glass slide washing and contaminated pipettes, used for specimen transfer may cause false-positive reactions, however, our laboratory uses manufacturer provided test-cards instead of glass slides, and sterile pipettes. Apart from HIV infection, none of the autoimmune, infective, malignant or substance cross reactions were implicated in our patient and we thus postulate that this false-positive reaction was probably related to HIV infection.
Cryptococcal LFA is a highly sensitive and specific diagnostic test and given the ease of use, minimal laboratory requirements, potential low cost and temperature stability, it shows great promise as a Point of Care test for the diagnosis of cryptococcosis [10] . When infantile cryptococcosis is suspected, an effort should be made to confirm it by evaluating the mother's health, repeating the test result in CSF and/ or blood and by sending the specimens for additional confirmatory testing. Conceivably, false-positive CLATs may detect exposure to transplacentally acquired maternal antigen in the absence of infection. Contamination of clinical specimens may also result in false-positive test reactions. Once the diagnosis is confirmed or there is strong clinical suspicion which warrants therapy, there are available guidelines for treatment of older children and adults [11] but limited guidance for treating infants and young children. A case report from China of a 4 month old premature baby with cryptococcus detected on CSF antigen and culture, describes successful treatment with amphotericin B plus flucytosine for two weeks, followed by high dose fluconazole for 8 weeks and lower dose maintenance fluconazole thereafter [12] . We opted to initially treat with amphotericin B as per national adult guidelines [11] . Evidence suggests better outcomes with initial amphotericin B (with or without 5-flucyotosine) compared to fluconazole therapy alone [413] .
In conclusion, although cryptococcosis is common in the adult HIV population, it is uncommon in children and extremely rare in neonates. The reason that it may be so rare is that serological studies suggest that exposure usually occurs after the first two years of life [14] . Another reason may be the difference in immune response. However the diagnosis may be considered in premature infants, infants of mothers with confirmed cryptococcosis, and more severely immunocompromised older children and adolescents. While usually highly specific, positive cryptococcal latex antigen tests in the absence of confirmatory microscopic or culture results should be treated with caution as false-positive results do occur. Cryptococcal LFA could be considered before administering extended courses of treatment.
